RT Journal Article
SR Electronic
T1 Efficacy of SARS-CoV-2 wastewater surveillance for detection of COVID-19 at a residential private college
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.15.21263338
DO 10.1101/2021.09.15.21263338
A1 Landstrom, Michelle
A1 Braun, Evan
A1 Larson, Ellen
A1 Miller, Merrill
A1 Holm, Geoffrey H.
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.15.21263338.abstract
AB Many colleges and universities utilized wastewater surveillance testing for SARS-CoV-2 RNA as a tool to help monitor and mitigate the COVID-19 pandemic on campuses across the United States during the 2020-2021 academic year. We sought to assess the efficacy of one such program by analyzing wastewater RNA load data in relation to SARS-CoV-2 cases identified through individual surveillance testing. Almost 80% of the cases on campus were associated with positive wastewater tests, resulting in an overall positive predictive value of ∼79% (Chi square 48.1, Df = 1, p < 0.001). However, half of the positive wastewater samples occurred in the two weeks following the return of a student to the residence hall following isolation, and therefore were not useful in predicting new infections. When these samples were excluded, the positive predictive value of a positive wastewater sample was ∼54%. Overall, we conclude that the continued shedding of viral RNA by patients past the time of potential transmission confounds the identification of new cases using wastewater surveillance, and decreases its effectiveness in managing SARS-CoV-2 infections on a residential college campus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded entirely by Colgate University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was ruled as exempt from the review process by the Colgate University Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data related to this project is available at figshare.com, licensed CC by 4.0 https://doi.org/10.6084/m9.figshare.16563729.v1